产品名称: | Streptococcus agalactiae Lehmann and Neumann |
---|---|
商品货号: | TS139949 |
Strain Designations: | M781 |
Application: | Produces capsular polysaccharide type III |
Isolation: | Cerebrospinal fluid of an infant with neonatal meningitis, 1978 |
Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Antigenic Properties: | Serotype III |
Product Format: | freeze-dried |
Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
Preceptrol®: | no |
Type Strain: | no |
Medium: | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
Growth Conditions: | Temperature: 37°C
Atmosphere: Aerobic |
Name of Depositor: | CJ Baker |
Special Collection: | NCRR Contract |
Year of Origin: | 1978 |
References: | Anderson DC, et al. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr. Res. 17: 496-502, 1983. PubMed: 6348689 Kasper DL, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98: 2308-2314, 1996. PubMed: 8941648 BD MAX™ GBS Assay. BD Becton Dickinson. |